Previous research has shown that chronic obstructive pulmonary disease (COPD) is associated with eosinophilic airway inflammation in 10-20% of patients. Benralizumab, a monoclonal antibody, has been shown to decrease the number of blood and sputum eosinophils. In this trial of 101 patients with COPD whether benralizumab reduces the number of acute exacerbations was investigated. Benralizumab was found to be no more effective at preventing acute COPD exacerbations ...
Read More
You have just read an article categorized health
titled Research Explores Use of Benralizumab for Chronic Obstructive Pulmonary Disease.
Written by:
editor -
Monday, September 8, 2014
There are currently no comments for "Research Explores Use of Benralizumab for Chronic Obstructive Pulmonary Disease"
Post a Comment